Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

ChinaBio® Stock Index Drops 57% in 2008

publication date: Jan 2, 2009

You knew it was bad. And you were right. In calendar year 2008, the ChinaBio® Stock Index fell 57%, dropping from 1674 at the end of 2007 to 719 one year later, a 915 point decline. The index is made up of 15 China-based biopharmas that trade in the US. It was not a pleasant journey. At the beginning of 2008, China stocks were the darlings of the world. At year’s end, the same companies were considered risky in the context of a very negative overall market in which risk is to be avoided. More details...



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital